Effects of lacosamide, pregabalin, and tapentadol on pain-processing biomarkers by nerve excitability testing

Phase 2, randomised, double-blind trial of lacosamide, pregabalin and tapentadol in pain (4 arms), sponsored by Aarhus University. Primary endpoints: Change in strength duration time constant in large sensory fibers on non-sensitized skin and Change in strength duration time constant in large motor fibers on non-sensitized skin. Started Jun 2019; status: completed.